Vanda Pharmaceutical News Today

Investment firm Shareholder Capital sent a letter to drugmaker Vanda Pharmaceuticals board on Thursday asking it to reconsider Future Paks takeover offer. On April 17, Vanda rejected...

Health news and commentary gathered by <em>MedPage Today</em> staff

(Reuters) -The U.S. FDA approved Vanda Pharmaceuticals' drug to treat manic and mixed episodes associated with a type of bipolar disorder, the company said on Tuesday, marking the second approval for the treatment. Shares of the Washington, D.C.-based ...

The FDA approved iloperidone for acute treatment of bipolar I disorder on April 02, 2024, according to Vanda Pharmaceuticals.

The U.S. FDA approved Vanda Pharmaceuticals drug to treat manic and mixed episodes associated with a type of bipolar disorder, the company said on Tuesday, marking the second approval for the...

The U.S. FDA approved Vanda Pharmaceuticals drug to treat manic and mixed episodes associated with a type of bipolar disorder, the company said on Tuesday, marking the second approval for the...

(Reuters) -The U.S. FDA approved Vanda Pharmaceuticals drug to treat manic and mixed episodes associated with a type of bipolar disorder, the company said ...

NEW YORK, March 31, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Vanda Pharmaceutical Inc. (“Vanda” or the “Company”) (NASDAQ: VNDA). Such investors are

NEW YORK, March 27, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Vanda Pharmaceutical Inc.  . Such investors are advised to contact Danielle Peyton at...

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Vanda Pharmaceutical Inc. ("Vanda" or the "Company") (NASDAQ: VNDA). Such...